Viewing Study NCT06339138



Ignite Creation Date: 2024-05-06 @ 8:19 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06339138
Status: RECRUITING
Last Update Posted: 2024-04-01
First Post: 2024-03-25

Brief Title: Identification of Novel High Quality Methylated DNA Markers in Renal Tumors Whole Methylome Discovery Tissue Validation and Feasibility Testing In Blood and Urine The INQUIRE Study
Sponsor: Mayo Clinic
Organization: Mayo Clinic

Study Overview

Official Title: Identification of Novel High Quality Methylated DNA Markers in Renal Tumors Whole Methylome Discovery Tissue Validation and Feasibility Testing in Blood and Urine
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is being done to collect blood tissue and urine samples to identify a novel high quality methylated DNA marker in patients with renal tumors
Detailed Description: PRIMARY OBJECTIVES

I In tissue to discover and validate DNA methylation markers MDMs for detection of malignant renal and urothelial tumors

II In blood to assess the accuracy of candidate MDMs from above for detection of malignant renal and urothelial tumors

OUTLINE This is an observational study

Participants may undergo blood urine and tissue sample collection on study Participants medical records are also reviewed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
17-010944 OTHER Mayo Clinic in Rochester None
NCI-2024-00971 REGISTRY None None